The authors explore the clinical and economic evidence of the benefit of rTMS and discuss the impact of restricting access to the therapy through overly aggressive prior authorization practices.
Peer-influenced content. Sources you trust. No registration required. This is HCN.
The authors explore the clinical and economic evidence of the benefit of rTMS and discuss the impact of restricting access to the therapy through overly aggressive prior authorization practices.